Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

42.96USD
14 Dec 2017
Change (% chg)

$-0.72 (-1.65%)
Prev Close
$43.68
Open
$43.77
Day's High
$43.94
Day's Low
$42.94
Volume
756,635
Avg. Vol
919,307
52-wk High
$46.80
52-wk Low
$35.78

Latest Key Developments (Source: Significant Developments)

Third Respiratory Assay now FDA cleared on Hologic's new Panther Fusion system
Wednesday, 6 Dec 2017 08:08am EST 

Dec 6 (Reuters) - Hologic Inc ::THIRD RESPIRATORY ASSAY NOW FDA CLEARED ON HOLOGIC'S NEW PANTHER FUSION® SYSTEM.HOLOGIC INC - ‍RECEIVED 510(K) CLEARANCE FROM FDA FOR PANTHER FUSION ADV/HMPV/RV ASSAY, A MULTIPLEXED ASSAY THAT RUNS ON NEW PANTHER FUSION SYSTEM​.  Full Article

HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE
Friday, 24 Nov 2017 08:05am EST 

Nov 24 (Reuters) - Hologic Inc ::HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE.HOLOGIC INC- ‍HAS RECEIVED 510(K) CLEARANCE FROM U.S. FOOD AND DRUG ADMINISTRATION FOR QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE​.  Full Article

Hologic announces Q4 GAAP earnings per share $0.29
Wednesday, 8 Nov 2017 04:01pm EST 

Nov 8 (Reuters) - Hologic Inc ::Hologic announces financial results for fourth quarter of fiscal 2017.Q4 non-GAAP earnings per share $0.50.Q4 GAAP earnings per share $0.29.Q4 earnings per share view $0.49 -- Thomson Reuters I/B/E/S.Q4 revenue $802.9 million versus I/B/E/S view $792.5 million.Hologic Inc - ‍expect to post solid, mid-single-digit organic revenue growth in fiscal 2018​.  Full Article

Hologic - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​
Thursday, 26 Oct 2017 08:07am EDT 

Oct 26 (Reuters) - Hologic Inc :Hologic Inc - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​.  Full Article

Hologic prices offering of $350 mln 4.375 pct senior notes due 2025
Wednesday, 4 Oct 2017 06:01pm EDT 

Oct 4 (Reuters) - Hologic Inc ::Hologic announces pricing of offering of $350 million aggregate principal amount of 4.375% senior notes due 2025.Private offering at an issue price of $1,000 per $1,000​.  Full Article

Hologic announces offering of $350 mln of senior notes due 2025
Wednesday, 4 Oct 2017 07:02am EDT 

Oct 4 (Reuters) - Hologic Inc : :Hologic announces offering of $350 million of senior notes due 2025.Hologic- intends to use proceeds of offering and available cash to retire company's remaining convertible notes due in December of 2017, March of 2018.  Full Article

Hologic enters into amended and restated five-year secured credit agreement
Wednesday, 4 Oct 2017 07:02am EDT 

Oct 4 (Reuters) - Hologic Inc : :Hologic enters into amended and restated five-year secured credit agreement.Initial proceeds from new $1.5 billion term loan and $1.5 billion revolving credit line used to refinance senior secured debt.Funds also expected to contribute to retirement of remaining convertible notes.Hologic - ‍entered amended, restated credit agreement consisting of new, five-year $1.5 billion senior term loan and $1.5 billion revolving credit facility​.New loan facilities mature on October 3, 2022, subject to adjustment in certain circumstances.Borrowings initially bear interest at an annual rate of libor + 1.50%, and may change based on Hologic's leverage ratio.Hologic Inc - ‍new loan facilities mature on October 3, 2022​.In connection with refinancing, Hologic terminated its previous $1 billion revolving credit facility.  Full Article

Hologic receives FDA 510(k) clearance to market SculpSure
Wednesday, 27 Sep 2017 08:00am EDT 

Sept 27 (Reuters) - Hologic Inc :Hologic receives FDA 510(k) clearance to market SculpSure for non-invasive body contouring (lipolysis) of the submental area (under the chin).Hologic Inc - ‍FDA granted an expanded FDA 510(k) clearance for Cynosure's non-invasive body contouring product, SculpSure​.  Full Article

Hologic updates on commercial availability of Brevera Breast Biopsy System
Thursday, 31 Aug 2017 08:00am EDT 

Aug 31 (Reuters) - Hologic Inc ::Hologic inc - ‍U.S. commercial availability of Brevera Breast Biopsy System with Corlumina imaging technology​.  Full Article

Hologic updates on FY17 profit outlook
Thursday, 3 Aug 2017 10:35am EDT 

Aug 3 (Reuters) - Hologic Inc :Hologic says ‍updated Q3 financial results press release to correct tax impact of certain exclusions in FY net income per share guidance​ - SEC filing.Hologic - ‍result of update was increase in FY net income per share guidance to a range of $2.55 to $2.57, from a prior range of $2.49 to $2.51​.Hologic Inc - ‍company's FY non-gaap guidance remains unchanged​.FY 2017 earnings per share view $2.01 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Third Respiratory Assay now FDA cleared on Hologic's new Panther Fusion system

* THIRD RESPIRATORY ASSAY NOW FDA CLEARED ON HOLOGIC'S NEW PANTHER FUSION® SYSTEM